Outcome
In this study we compare a combination of oseltamivir with routine
regimen (oselta group), with routine regimen alone as a control group
(control group), to evaluate the efficacy of oseltamivir in the
treatment and outcome of Covid-19 infected patients.
The primary endpoint was the duration of hospitalization (length of
hospital stay). The secondary endpoints were, requirement to admission
to the intensive care unit (ICU), mechanical ventilation, and patient’s
outcome discharge or mortality.